Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yishenhuazhuo granules in low-risk idiopathic membranous nephropathy (Qi deficiency of spleen/kidney with blood stasis)
CTR20231082Phase 2Active
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Sep 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Yishen Huazhuo Granules in idiopathic membranous glomerulonephritis (IMG), sponsored by Tianjin Institute of Pharmaceutical Research. Started Sep 2023; status: active.
02
Drugs
Yishen Huazhuo Granules
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on CTR20231082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231082.